This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

11 Jun 2012

Bausch + Lomb Bolsters Product Portfolio with ISTA Acquisition

Bausch + Lomb has completed its acquisition of ISTA Pharmaceuticals.

Global eye health company Bausch + Lomb has boosted its product portfolio and pipeline with the acquisition of ISTA Pharmaceuticals.


ISTA is a leading pharmaceutical company with four prescription products: Bromday, Bepreve, Istalol and Vitrase.


These now join Bausch + Lomb's existing portfolio, which includes products such as Lotemax and Besivance.


Bausch + Lomb has acquired ISTA Pharmaceuticals for approximately $500 million in a deal described as an "exciting development for eye health".


"Together, we are building a high-performance company that can deliver even more benefits for the patients and customers

Related News